Company news
TrivarX Limited news in 2018
TrivarX Limited's news releases, calls and decks from 2018, newest first.
Converting Note & Non-Renounceable Entitlement Offer
December 9, 2018
Exclusive Agreement Signed for ilumen Pilot Program
November 26, 2018
Response to ASX Appendix 4C Query
November 14, 2018
Medibio Provides Update on FDA Process
November 8, 2018
Medibio Appoints CEO and Managing Director
November 1, 2018
MEB Signs ilumen Contract with Large Australian Employer
October 23, 2018
Receipt of R&D Tax Incentive Refund
October 14, 2018
Medibio Releases Corporate Health Product, ilumen
October 3, 2018
Notice Received Under Section 249D of the Corporations Act
October 1, 2018
Executive Leadership Changes
September 20, 2018
Clinical Study Shows Improvement to Diagnostic Standard
September 5, 2018
Preliminary Final Report
August 29, 2018
Departure of Managing Director & Chief Executive Officer
August 28, 2018
Medibio Submits FDA De Novo Application
July 15, 2018
Medibio Receives TGA Approval
June 19, 2018
MEB Signs Global Contract with Jacobs Engineering
May 25, 2018
Medibio Announces Next Tranche of Corporate Health Contracts
May 9, 2018
Medibio Signs First Corporate Health Contract
May 8, 2018
Medibio Receives CE Certification
May 2, 2018
MEB signs binding term sheet to acquire Vital Conversations
March 4, 2018
Medibio Quarterly Update and Cash Flow Report
January 30, 2018
Agreement with Striiv to Accelerate Commercialisation
January 21, 2018
Medibio Announces ISO 13485 Certification
January 10, 2018